Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BNTX |
---|---|---|
09:32 ET | 17870 | 114.115 |
09:33 ET | 3989 | 115.0122 |
09:35 ET | 11957 | 114.905 |
09:37 ET | 27186 | 115.575 |
09:39 ET | 4536 | 115.195 |
09:42 ET | 9521 | 114.745 |
09:44 ET | 5292 | 114.54 |
09:46 ET | 4122 | 113.9 |
09:48 ET | 4844 | 113.805 |
09:50 ET | 4500 | 113.585 |
09:51 ET | 4171 | 114.3499 |
09:53 ET | 2500 | 114.21 |
09:55 ET | 15628 | 114.3 |
09:57 ET | 2732 | 114.77 |
10:00 ET | 1419 | 115.13 |
10:02 ET | 2008 | 115.2225 |
10:04 ET | 3245 | 115.5 |
10:06 ET | 5107 | 115.65 |
10:08 ET | 6931 | 115.375 |
10:09 ET | 3509 | 115.25 |
10:11 ET | 1871 | 115.35 |
10:13 ET | 1834 | 115.22 |
10:15 ET | 600 | 115.2675 |
10:18 ET | 7278 | 114.57 |
10:20 ET | 3020 | 114.305 |
10:22 ET | 7556 | 115.08 |
10:24 ET | 2202 | 115.34 |
10:26 ET | 2867 | 115 |
10:27 ET | 1156 | 114.265 |
10:29 ET | 3800 | 114.385 |
10:31 ET | 1200 | 114.04 |
10:33 ET | 1281 | 113.95 |
10:36 ET | 465 | 114 |
10:38 ET | 12155 | 114.29 |
10:40 ET | 12573 | 114.23 |
10:42 ET | 100 | 113.785 |
10:44 ET | 4060 | 113.395 |
10:45 ET | 2057 | 113.615 |
10:47 ET | 762 | 113.145 |
10:49 ET | 1439 | 112.94 |
10:51 ET | 3203 | 113.25 |
10:54 ET | 2400 | 113.18 |
10:56 ET | 1109 | 113.5689 |
10:58 ET | 1967 | 113.975 |
11:00 ET | 2047 | 113.955 |
11:02 ET | 1075 | 114.08 |
11:03 ET | 3885 | 113.76 |
11:05 ET | 2789 | 113.94 |
11:07 ET | 984 | 114.11 |
11:09 ET | 1138 | 113.995 |
11:12 ET | 100 | 113.87 |
11:14 ET | 666 | 113.88 |
11:16 ET | 829 | 113.75 |
11:18 ET | 3805 | 113.2 |
11:20 ET | 2221 | 112.97 |
11:21 ET | 300 | 112.86 |
11:23 ET | 940 | 113.46 |
11:25 ET | 200 | 113.46 |
11:27 ET | 817 | 113.3 |
11:30 ET | 400 | 113.21 |
11:32 ET | 100 | 113.21 |
11:34 ET | 2000 | 112.99 |
11:36 ET | 900 | 112.87 |
11:38 ET | 1200 | 112.8 |
11:39 ET | 2232 | 112.6 |
11:41 ET | 1107 | 112.78 |
11:43 ET | 800 | 112.78 |
11:45 ET | 1065 | 112.5 |
11:48 ET | 1300 | 112.52 |
11:50 ET | 400 | 112.65 |
11:52 ET | 1409 | 112.86 |
11:54 ET | 1732 | 112.54 |
11:56 ET | 2497 | 112.555 |
11:57 ET | 600 | 112.515 |
11:59 ET | 400 | 112.43 |
12:01 ET | 200 | 112.55 |
12:03 ET | 100 | 112.465 |
12:06 ET | 1602 | 112.59 |
12:08 ET | 200 | 112.56 |
12:10 ET | 400 | 112.56 |
12:12 ET | 200 | 112.56 |
12:14 ET | 100 | 112.65 |
12:15 ET | 1200 | 112.325 |
12:17 ET | 100 | 112.26 |
12:19 ET | 600 | 112.22 |
12:21 ET | 2057 | 112.52 |
12:24 ET | 1700 | 112.6 |
12:26 ET | 1587 | 112.84 |
12:28 ET | 1762 | 112.63 |
12:32 ET | 1583 | 112.6 |
12:33 ET | 1700 | 112.36 |
12:35 ET | 3193 | 112.64 |
12:37 ET | 367 | 112.58 |
12:39 ET | 950 | 112.5301 |
12:44 ET | 100 | 112.61 |
12:46 ET | 5626 | 112.66 |
12:48 ET | 500 | 112.69 |
12:50 ET | 4906 | 112.83 |
12:51 ET | 300 | 112.72 |
12:53 ET | 600 | 112.6 |
12:55 ET | 2209 | 112.61 |
12:57 ET | 1840 | 112.5 |
01:00 ET | 1100 | 112.25 |
01:02 ET | 2130 | 112.31 |
01:06 ET | 800 | 112.2 |
01:08 ET | 3305 | 112.02 |
01:09 ET | 5875 | 111.85 |
01:11 ET | 3933 | 111.97 |
01:15 ET | 200 | 111.84 |
01:18 ET | 1670 | 111.7 |
01:20 ET | 789 | 111.705 |
01:22 ET | 2390 | 111.705 |
01:24 ET | 400 | 111.58 |
01:26 ET | 903 | 111.55 |
01:27 ET | 6148 | 111.335 |
01:29 ET | 800 | 111.335 |
01:31 ET | 200 | 111.32 |
01:33 ET | 300 | 111.19 |
01:36 ET | 1100 | 111.38 |
01:38 ET | 900 | 111.2 |
01:40 ET | 4240 | 111.47 |
01:42 ET | 400 | 111.26 |
01:44 ET | 100 | 111.3 |
01:45 ET | 1596 | 111.5 |
01:47 ET | 500 | 111.455 |
01:49 ET | 1015 | 111.44 |
01:51 ET | 300 | 111.44 |
01:54 ET | 2372 | 111.45 |
01:56 ET | 2474 | 111.235 |
01:58 ET | 400 | 111.23 |
02:00 ET | 1020 | 110.92 |
02:02 ET | 1544 | 110.98 |
02:03 ET | 967 | 111.09 |
02:05 ET | 100 | 110.99 |
02:07 ET | 1685 | 110.76 |
02:09 ET | 400 | 110.73 |
02:12 ET | 100 | 110.67 |
02:14 ET | 200 | 110.805 |
02:16 ET | 722 | 110.845 |
02:18 ET | 235 | 110.8211 |
02:20 ET | 1516 | 110.94 |
02:21 ET | 1400 | 110.85 |
02:23 ET | 1215 | 110.705 |
02:25 ET | 1753 | 110.67 |
02:27 ET | 2221 | 110.47 |
02:30 ET | 2429 | 110.53 |
02:32 ET | 100 | 110.56 |
02:34 ET | 2447 | 110.54 |
02:36 ET | 619 | 110.45 |
02:38 ET | 1467 | 110.37 |
02:39 ET | 2252 | 110.62 |
02:41 ET | 1025 | 110.68 |
02:43 ET | 656 | 110.52 |
02:45 ET | 600 | 110.52 |
02:48 ET | 1500 | 110.48 |
02:50 ET | 900 | 110.4325 |
02:52 ET | 1062 | 110.34 |
02:54 ET | 2067 | 110.2398 |
02:56 ET | 500 | 110.07 |
02:57 ET | 3816 | 109.83 |
02:59 ET | 807 | 109.8 |
03:01 ET | 1700 | 109.6 |
03:03 ET | 3809 | 109.55 |
03:06 ET | 2917 | 109.58 |
03:08 ET | 2551 | 109.54 |
03:10 ET | 1950 | 109.63 |
03:12 ET | 10047 | 109.44 |
03:14 ET | 5106 | 109.64 |
03:15 ET | 4704 | 109.775 |
03:17 ET | 2844 | 109.69 |
03:19 ET | 600 | 109.62 |
03:21 ET | 2548 | 109.17 |
03:24 ET | 1512 | 108.945 |
03:26 ET | 4668 | 109.22 |
03:28 ET | 850 | 108.95 |
03:30 ET | 2800 | 108.95 |
03:32 ET | 15974 | 108.655 |
03:33 ET | 6228 | 107.9201 |
03:35 ET | 7027 | 107.91 |
03:37 ET | 21466 | 107.61 |
03:39 ET | 17557 | 106.885 |
03:42 ET | 38017 | 106.015 |
03:44 ET | 17326 | 106.37 |
03:46 ET | 44305 | 105.021 |
03:48 ET | 46723 | 105.345 |
03:50 ET | 26400 | 104.81 |
03:51 ET | 34901 | 105.335 |
03:53 ET | 33068 | 104.325 |
03:55 ET | 128849 | 102.545 |
03:57 ET | 45683 | 103.26 |
04:00 ET | 259948 | 103.56 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biontech SE | 26.7B | -50.3x | --- |
Incyte Corp | 15.5B | 555.4x | +39.11% |
Charles River Laboratories International Inc | 10.6B | 24.6x | +15.57% |
United Therapeutics Corp | 17.9B | 17.0x | +8.22% |
argenx SE | 36.2B | -708.5x | --- |
BioMarin Pharmaceutical Inc | 12.7B | 39.4x | --- |
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $24.8B |
---|---|
Revenue (TTM) | $3.2B |
Shares Outstanding | 239.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.19 |
EPS | $-2.06 |
Book Value | $89.68 |
P/E Ratio | -50.3x |
Price/Sales (TTM) | 7.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -30.81% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.